BG Medicine Receives $15M Loan from GE Capital

BG Medicine, Inc., a Waltham, Massachusetts-based life sciences company, has received a $15 million multi-draw senior secured term loan facility from GE Capital, Healthcare Financial Services.

The company intends to use the financing for its commercialization efforts and additional growth.

Led by Michael W. Rogers, executive vice president and CFO, BG Medicine focuses on the discovery, development, and commercialization of novel, biomarker-based diagnostics. The company, which recently launched the BGM Galectin-3TM test for use in patients with heart failure, also has products in development to aid in the diagnosis and management of acute atherothrombosis and lipid disorders.



Join the discussion